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Introduction 
 
  The dissolution of orally administered solid dosage forms is a critical quality aspect, that can 
affect the bioavailability and pharmacokinetic (PK) profile, and eventually, the efficacy and safety of 
the drug products [1]. After a drug product is orally administered, the drug substance undergoes 
dissolution, membrane permeation, distribution, metabolism, and excretion in vivo (Figure 1). While 
the behavior of a drug substance during processes occurring after membrane permeation depends on 
the type of the drug substance, the dissolution process can be controlled by the drug product 
independently of the drug substance. Thus, the control of in vivo dissolution can contribute to control 
of the PK profile through the control of absorption. Many attempts have been made to control in vivo 
dissolution, and many types of controlled-release drug products have been developed to achieve the 
expected in vivo dissolution in the gastrointestinal tract and yield PK profiles different from those 
obtained with general immediate-release drug products. Enteric drug products are designed not to 
dissolve in stomach and dissolve in intestine. Extended-release drug products are designed to 
dissolve slowly for a few hours or more. To achieve such unusual dissolution, controlled-release 
drug products tend to have the complex formulation and/or complicated dissolution mechanism. The 
need to develop such difficult pharmaceutical product is increasing in the pharmaceutical industry. 
  Drug dissolution from drug products depends not only on the dissolution properties of the drug 
itself but also on the formulation (excipients and composition) and the manufacturing process of the 
drug product, as well as the properties of the medium in which the drug is dissolved, such as the pH, 
salt, and surfactant concentration [2]. Since many factors contribute to drug dissolution from the 
drug product, the dissolution process is very complex, leading to difficulties in controlling the 
process. Therefore, for pharmaceutical product development and quality control of orally 
administered drug products, it is essential to understand the dissolution mechanism and identify the 
key factors affecting the dissolution properties to control them properly. 
  Among analytical techniques, spectroscopic techniques such as infrared (IR), near-IR (NIR), 
Raman, and X-ray spectroscopy are extremely powerful tools for evaluation of drug products 
because of their ability to provide quick and nondestructive measurements [3]. In addition, a single 
spectrum obtained by one-time measurements using a spectroscopic technique contains a large 
amount of information. Depending on the type of technique used, the spectrum can contain 
information regarding the molecule structure, crystal structure, component composition, and/or  
other physicochemical properties of the target material [3]. These characteristics of spectroscopic 
techniques enable nondestructive prediction of the physicochemical properties of the drug product or 
real-time monitoring of its dynamic physicochemical properties, including dissolution. Actually, 
these techniques are used as process analytical technology (PAT) tools for real-time monitoring of 
the manufacturing process and applied for real-time release (RRT) testing [4]. 
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  Given both the complex nature of drug product dissolution and characteristics of spectroscopic 
techniques, it was deemed appropriate that spectroscopic techniques be applied for identification of 
the key factors and elucidation of the mechanism of drug dissolution from orally administered solid 
dosage forms. Although there are many types of orally administered drug products and multiple 
types of dissolutions, two topics were selected for research in this doctoral dissertation: (1) the delay 
effect of magnesium stearate on tablet dissolution in an acidic medium and (2) non-destructive 
prediction of enteric coating layer thickness and drug dissolution rate by near-infrared spectroscopy 
(NIRS) and X-ray computed tomography (CT). In the assessment of each of these topics, different 
spectroscopic techniques were applied to different targets and for different purposes. In the former 
case, scanning electron microscopy-energy dispersion spectroscopy (SEM-EDS) and attenuated total 
reflection-Fourier transform infrared spectroscopy (ATR-FTIR) were used to elucidate the 
dissolution-retardation mechanism mediated by magnesium stearate (Mg-St) in immediate-release 
tablets: in the latter case, NIRS and X-ray CT were used to identify the key factors that determine 
the dissolution rate of enteric-coated tablets.  
  Spectroscopic techniques have many advantages like quick and nondestructive measurements, and 
large amount and detailed information available. One type of spectroscopic techniques like FTIR and 
NIRS enables monitoring of the chemical change of the target material at a molecular level, and 
another type like SEM and X-ray CT enables micro-level spatial analysis of targets. On the other 
hand, they often require analysis/processing techniques to extract the target information from the 
spectrum data. One spectrum contains a large amount of information incorporating the spectra 
derived from multiple sources and does not present a specific result. Thus, analysts must analyze the 
spectrum to understand what each peak represents and process the spectrum to extract the 
information they need by using general databases or comparing the findings with results obtained by 
other techniques. Therefore, it is also important to establish the analysis/processing procedures for 
spectroscopic techniques. In this regard, the purpose of my research is to establish some 
spectroscopic approaches for identification of key factors and elucidation of the mechanism of drug 
dissolution from orally administered solid dosage forms from an analytical scientist’s perspective. If 
these approaches are established, they would facilitate pharmaceutical product development, which 
has become increasingly complicated, and eventually allow advancement of research in the area of 
formulation development. 
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Figure 1  Illustration of in vivo behavior of drug substance from orally administered drug product 
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Study 1: Delay effect of magnesium stearate on tablet dissolution in 
acidic medium 
 
1. Background 
  Magnesium stearate (Mg-St) is a traditional and commonly used lubricant for solid dosage 
formulations [5], and is also known to delay tablet dissolution because of its hydrophobicity [6]. 
Although there have been many studies investigating the mechanism of action and characteristics of 
Mg-St [7–9], there is still room for investigation, and some problems related to Mg-St are still being 
reported, for example, the decrease of tablet hardness, sticking trouble, and over lubrication by over 
mixing [10–13], which sometimes induces the delay of tablet disintegration/dissolution [14,15]. 
  When in vitro dissolution tests were conducted for one brand of marketed metformin HCl 500 mg 
tablets, dissolution profiles varied depending on the pH of the medium, in spite of the constant high 
solubility of metformin HCl being independent of pH. Because components other than Mg-St in the 
tablet formulation were soluble, the properties of Mg-St were briefly investigated. The different 
properties of Mg-St in media of different pH and the correlation between Mg-St dispersibility and 
dissolution rate of the tested tablet was suggested, and thus, these properties were investigated in this 
study using commercial metformin HCl tablets and prepared model metformin HCl tablets. 
  There have been many studies which conducted the comparison of the disintegration and 
dissolution of tablets containing different kinds of lubricant [16–18], different kinds or amounts of 
Mg-St [19,20], or tablets manufactured with the same formulation but different process parameters. 
However, few studies have examined the drug dissolution mechanism from tablet containing Mg-St. 
In this study, the mechanism of action by which Mg-St delays tablet dissolution was investigated 
using spectroscopic techniques, and the behavior of Mg-St was examined in acidic and neutral pH 
conditions reflecting stomach and intestinal pH environment. 
 
 
2. Materials and methods 
2.1 Materials 
2.1.1. Materials 
  Three commercial metformin HCl 500 mg tablets were purchased and used for dissolution tests. 
  For preparation of model tablets, metformin HCl was purchased from Farmhispania S.A. 
(Barcelona, Spain), which meets the specifications in Japanese Pharmacopoeia (JP), European 
Pharmacopoeia (Ph.Eur.), and the U.S. Pharmacopeia (USP). Its crystal form was the known 
thermodynamically stable form. Povidone (polyvinylpyrrolidone) was purchased from BASF 
(Ludwigshafen，Germany), Mg-St was purchased from Wako Pure Chemical Industries, Ltd. (Tokyo, 
Japan), and they were used for preparation of model tablets.  
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  Stearic acid (>98.0%) and Mg-St purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, 
Japan) were used for obtaining reference IR spectra. 
 
2.1.2. Preparation of model tablets 
  To prepare wet granules, 9.5 g of metformin HCl and 0.5 g of povidone were mixed in a mortar 
with the gradual addition of 1.5 mL of water. Then, extruding granulation was carried out using an 
850-μm screen, and the wet granules were dried for 1 day at 70ºC. The subsequent granules were 
compressed with a compression testing machine (TG-50KN, Minebea Co., Ltd., Nagano, Japan) 
with a diameter of 8 mm. The 200 mg tablets were prepared with a compression speed of 10 
mm/min and a pressure of 13 kN, without Mg-St (“Mg-St(-)” tablets). 
  The tablets containing 1% Mg-St (“Mg-St(+)” tablets) were prepared by adding 1% (w/w) Mg-St 
to the dried granules. The granules were mixed for 1 min and compressed under the same conditions 
as the “Mg-St(-)” tablets. 
 
2.1.3. Preparation of dissolution medium 
  For the dissolution tests of commercial metformin HCl tablets, the recommended dissolution 
media described in Ph.Eur. were used: simulated gastric fluid without pepsin (SGF, c.a. pH 1.2), 
acetate buffer (c.a. pH 4.5), and phosphate buffer (c.a. pH 6.8).  
  For the other experiments, the 1st and 2nd fluid for dissolution test, described in JP, were used 
(“pH 1.2” and “pH 6.8”, respectively). pH 1.2 and pH 6.8 media containing 0.01% (w/v) MgSO4 
were also used (“pH 1.2 (Mg+)” and “pH 6.8 (Mg+)”, respectively). 
 
2.2 Methods 
2.2.1. Dissolution tests 
  A dissolution test apparatus (Evolution 6100, Distek, Inc., New Jersey) was used. The medium 
volume was 900 mL controlled at 37.2±0.5ºC during the test, and the basket rotation speed was 100 
rpm. Dissolution tests were conducted according to harmonized procedure within JP, Ph. Eur., and 
USP. The medium was removed at each time point and its drug concentration was analyzed by 
HPLC analysis. 
  An appropriate HPLC apparatus with UV detection unit for the determination purpose was used. 
The determination method by HPLC was validated one, and the HPLC operating conditions were as 
follows: the analytical column was C8 column, and the mobile phase was a mixture of aqueous 
solution, acetonitrile and sodium dodecyl phosphate, UV detection wavelength was 265 nm, and the 
isocratic programs was applied. 
 
2.2.2. Initial dissolution rate measurement 
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  The drug release rate from the tablet depends on not only the dissolution speed of components but 
also the tablet disintegration behavior, because changes in exposed surface area to the dissolution 
medium can influence the drug release rate. The stationary disk method is useful for examining the 
intrinsic drug release rate from tablet components keeping tablet surface area constant at the initial 
stage of dissolution studies while eliminating the drug size effect [21]. In this study, the tablet holder 
was used for the stationary disk method. The test tablet was placed into the holder to expose the 
single face (circle with 6 mm diameter) to the test solution and was suspended in the dissolution 
medium over the paddle as shown in Figure 2. The tablet was set so that its diametrical direction 
could be in line with the water flow.  
  A dissolution test apparatus (NTR-3000, Toyama Sangyo Co., Ltd., Toyama, Japan) and fiber 
multi-channel spectrometer (S-2450, Soma Optics, Ltd., Tokyo) were used. The medium volume was 
900 mL, controlled at 37.2±0.5ºC during the test, and the paddle rotation speed was 50 rpm. The 
probe of the spectrometer was dipped in the dissolution vessel and UV spectra of the medium were 
monitored during the dissolution tests with the following conditions: exposure time was 20 ms, light 
path length was 5 mm, measurement interval was 5 s, and cumulated number was 50. The detection 
wavelength was set at 235 nm for pH 1.2 medium and 245 nm for pH 6.8 medium in consideration 
of different UV spectrum pattern of metformin in both media. 
 
2.2.3. Elemental mapping of Mg on tablet surface by SEM-EDS 
  The distributions of Mg on the tablet surface before and during the dissolution test were observed 
under a scanning electron microscope (SEM, JSM-7600F, JEOL, Tokyo) with an energy dispersive 
X-ray spectrometer (EDS, JED-3200 Series, JEOL). The testing tablet was taken out from the 
medium after 5 min of dissolution according to the procedures in 2.2.2 and dried. The acceleration 
voltage was 15 kV, magnification ratio was x100, and measurement time was 10 h for the detection 
of Mg. 
 
2.2.4. ATR-FTIR analysis 
  A Fourier transform infrared spectroscopy (FTIR) apparatus (Spectrum One, Perkin Elmer, 
Massachusetts) was used for the surface measurement of the tablet. The scan range was 4000 – 400 
cm-1, resolution was 4 cm-1, and scan number was 4. Using attenuated total reflection (ATR) mode, 
where crystal material was diamond/KRS-5 and incident angle for the sample was about 45º, IR 
spectra of the tablet surface were obtained before and after 2 min of the dissolution studies of basket 
100 rpm according to the procedures in 2.2.1. 
  FTIR apparatus (IRTracer-100, Shimazu, Kyoto, Japan) was used to obtain the reference IR 
spectra of stearic acid and Mg-St. The measurement parameters used were the same as above. The 
spectra of Mg-St exposed to the media overnight were also obtained. 
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5. Noyes-Whitney equation 
  The drug dissolution rate can be represented by the Noyes-Whitney equation [22]: 
dC/dt = kS(CS - C)   (1) 
where CS is the solubility of the drug or the concentration of its saturated solution, C is the 
concentration of the dissolved drug at time t, S is the exposed surface area of the drug, and k is a 
constant specific to the drug. 
  When CS is much larger than C (for example, at the initial stage of dissolution), the equation can 
become: 
dC/dt = kSCS    (2) 
 
 
 
 
Figure 2  Diagram of stationary disk method. 
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3. Results and Discussion 
3.1. pH dependence of dissolution profiles of commercial metformin HCl tablets 
  To investigate the pH dependency of dissolution profiles of metformin HCl tablets, in vitro 
dissolution tests were conducted for three different metformin HCl 500 mg tablets marketed in 
different countries. Dissolution tests were done according to the test conditions described in the 
guideline (EMEA, 2010); the apparatus used was basket at 100 rpm and the dissolution medium was 
simulated gastric fluid without pepsin (SGF, c.a. pH 1.2), acetate buffer (c.a. pH 4.5), and phosphate 
buffer (c.a. pH 6.8). The obtained dissolution profiles are shown in Figure 3. All three kinds of 
tablets showed the same rank order of dissolution rate (pH 1.2 = pH 4.5 < pH 6.8) and the same 
dissolution process where the drug dissolution occurred on the tablet surface without disintegration. 
  Metformin HCl is a biguanide widely used for the treatment of type 2 diabetes mellitus [24]. The 
properties of metformin HCl is summarized in the review article [25]. The data in Japanese orange 
book shows that its aqueous solubility is consistently high in the physiological pH range and is 
independent of pH (333 mg/mL in pH 1.2, 353 mg/mL in pH 4.0, 355 mg/mL in pH 6.8 and 346 
mg/mL in water at 37ºC), and its pKa is 12.4. This constantly high solubility satisfied the sink 
condition for the dissolution tests, as shown in Figure 3; the solubility was more than one-hundred 
times the sink condition in every medium (against the maximum possible metformin concentration 
of 0.56 mg/mL = 500 mg/900 mL). Therefore, the difference in the drug dissolution rate in different 
pH media observed was not expected to be caused by the properties of metformin HCl itself. While 
every formulation tested was composed of metformin HCl, povidone, Mg-St, and hypromellose, the 
composition differed slightly between formulations based on slightly different tablet weight. Both 
povidone and hypromellose are water-soluble compounds, and only Mg-St is poorly soluble. 
  When Mg-St was added to these media, it tended to float on the surface of medium of pH 1.2 or 
pH 4.5 buffer. However, it dispersed in the pH 6.8 buffer. This varying tendency of Mg-St 
dispersibility could explain the observed tablet dissolution rate order of pH 1.2 = pH 4.5 < pH 6.8. 
Based on these observations, it was suggested that the difference in dissolution rate of these 
metformin HCl tablets in different pH media could be attributed to the properties of Mg-St. 
  In the following experiments, prepared model metformin HCl tablets were used to investigate the 
behavior of Mg-St contained in tablets, and JP 1st and 2nd fluid for dissolution test (pH 1.2 and pH 
6.8 media) were applied to investigate the dissolution behaviors of Mg-St and the tablets in acidic 
and neutral media. 
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Figure 3  Dissolution profiles in different pH media of metformin HCl 500 mg tablets marketed in 
different countries. Each dissolution profile is the average ± SD bar for all time points (n=12 each). 
 
 
3.2. Retardation of drug dissolution from tablets containing Mg-St 
  The dissolution rate of tablets depends on not only the physicochemical properties of the tablet 
components, such as solubility and diffusion coefficient, but also their exposed surface area to the 
dissolution medium [26], often expressed by the Noyes-Whitney equation (Eq. (1)). In the case of 
model metformin HCl 200 mg tablets, this equation can be simplified to Eq.2, because the solubility 
of metformin HCl (CS) is more than one-thousand times the sink condition against the possible 
maximum concentration of metformin in the vessel of 0.22 mg/mL = 200 mg/900 mL.  
  Through the course of dissolution studies, the surface area of tablets can change. For example, in 
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the case of non-disintegrating tablets, surface area decreases with a decrease in tablet size along with 
dissolution, and in the case of disintegrating tablets, surface area increases as tablets disintegrate to 
granules. The dissolution mechanism of both commercial metformin HCl 500 mg tablets and model 
metformin HCl 200 mg tablets was surface dissolution-limited dissolution without disintegration. To 
eliminate the influence of surface area decrease and investigate the intrinsic dissolution from the 
given surface area, the initial drug dissolution rates of prepared model tablets were measured by the 
stationary disk method by using both pH 1.2 and pH 6.8 media. The resulting dissolution profiles are 
shown in Figure 4. In both media, Mg-St(+) tablets showed slower drug dissolution than Mg-St(-) 
tablets because of the hydrophobic property of Mg-St, in spite of the very high solubility of 
metformin HCl. A larger retardation effect of Mg-St was observed in pH 1.2 medium than in pH 6.8 
medium; this is discussed later in this paper, and the common mechanism of dissolution retardation 
in both media by Mg-St is discussed in the following part. 
 
 
Figure 4 Initial dissolution rate profiles of Mg-St(-) tablets and Mg-St(+) tablets in pH 1.2 and pH 
6.8 media by stationary disk method. Each profile is the average with maximum-minimum bar for all 
time points (n=3 each). 
 
 
3.3. Limitation of tablet dissolution by Mg-St dissolution 
  Because the presence of Mg-St in tablets caused the delay of drug dissolution, it was suggested 
that the dissolution of Mg-St itself was controlling the dissolution of these tablets. Mg-St is a poorly 
water-soluble compound; its solubility in water is 4 mg/100 mL at 25ºC. Therefore, the solubility 
product of Mg-St should be taken into account for the dissociation of Mg-St into Mg2+ ions and 
stearic acid ions in the region near the tablet surface. If the dissolution medium is saturated by Mg2+ 
ions, the dissociation and dissolution of Mg-St are inhibited. 
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  To investigate the effect of Mg-St dissolution on the tablet dissolution, the dissolution studies 
were performed with media containing 0.01% MgSO4 (w/v), which corresponds to about 1 mmol/L 
Mg2+ ions. The resulting dissolution rate profiles are shown in Figure 5.  
  Then, the initial dissolution rate was calculated based on profiles in Figure 4 and Figure 5. The 
profiles showed that the drug dissolution rate of Mg-St(-) tablets was almost constant for the tested 5 
min; thus, the dissolution rate for Mg-St(-) tablets was calculated based on the profiles obtained 
during the initial 5 min. In contrast, the dissolution rates for Mg-St(+) tablets appeared to decrease in 
the later stage of dissolution. For Mg-St(+) tablets, dissolution rates in the initial 2 min and between 
2 and 5 min were calculated separately, and the dissolution rates during 2 to 5 minutes were used for 
the subsequent evaluation. The obtained dissolution rates are listed in Table 1. 
  The ratio of the dissolution rate in medium with MgSO4 to that in medium without MgSO4 was 
calculated for each tablet and in each pH medium. The ratios of Mg-St(-) and Mg-St(+) tablets in pH 
1.2 media were 0.97 and 0.81, respectively, and those in pH 6.8 media were 0.92 and 0.76, 
respectively. The ratios of Mg-St(-) tablets in both media were almost 1, indicating that the existence 
of Mg2+ ions had little influence on the dissolution of Mg-St(-) tablets. The ratios of Mg-St(+) tablets 
were less than those of Mg-St(-) tablets. These results indicated that the existence of Mg2+ ions 
delayed the dissolution of Mg-St(+) tablets, suggesting that the dissolution of Mg-St limits the tablet 
dissolution. 
 
 
Figure 5  Initial dissolution profiles of Mg-St(-)and Mg-St(+) tablets in pH 1.2 and pH 6.8 media 
containing 0.01% MgSO4 (w/v) by stationary disk method. Each profile is the average with 
maximum-minimum bar for all time points (n=3 each). pH 1.2 (Mg+): pH 1.2 medium containing 
0.01% MgSO4; pH 6.8 (Mg): pH 6.8 medium containing 0.01% MgSO4. 
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3.4. Elemental mapping of Mg on the tablet surface 
  To investigate the surface state of Mg-St(+) tablets, Mg distribution on the Mg-St(+) tablet surface 
before and during the dissolution test was observed by Mg detection with SEM-EDS. This is a 
general method used to observe Mg on the sample surface [27]. The Mg maps are shown in Figure 6. 
Compared to the surface before the dissolution, the increased amount of Mg was detected after 5 min 
of dissolution in both pH 1.2 and pH 6.8 media; hence, the maps show undissolved and remaining 
Mg on the surface of Mg-St(+) tablets during dissolution.  
  Because the SEM-EDS observation of Mg-St was based on magnesium derived from Mg-St, 
determination of Mg-St on the tablet surface was performed based on the stearyl (CH3(CH2)16COO-) 
or palmitic (CH3(CH2)14COO-) base derived from Mg-St by measuring ATR-FTIR. The surfaces of 
Mg-St(-) tablets and Mg-St(+) tablets were analyzed by ATR-FTIR before and after 2 min of 
dissolution to detect any chemical change of tablet surface components. The FTIR spectra are shown 
in Figure 7. In any spectrum of Mg-St(+) tablets, two characteristic peaks at about 2920 and 2850 
cm-1 were observed, which were not observed in the spectra of Mg-St(-) tablets. These peaks are 
derived from the aliphatic CH of the stearyl or palmitic base of Mg-St. Compared to the spectrum 
before dissolution, these peaks increased relatively after dissolution, which indicates the increase in 
the relative ratio of Mg-St on the tablet surface. These data also supported the increased amount of 
Mg-St exposed on the tablet surface after dissolution. Because of the slow dissolution rate of Mg-St, 
the amount of Mg remaining increased; therefore, the dissolution of Mg-St is the rate-limiting step of 
the tablet dissolution. 
  These observations of the relative increase of Mg-St on the Mg-St(+) tablet surface by dissolution 
are also consistent with the result that the initial dissolution rate of Mg-St(+) tablets decreases in the 
later stage of the profiles (2-5 min), as discussed in the results of initial dissolution rate. Along with 
the increase in the relative ratio of Mg-St on tablet surface by dissolution, the drug dissolution rate of 
Mg-St(+) tablets decreases more than the initial rate. 
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(a) pH 1.2 
 
(b) pH 6.8 
 
Figure 6  Mg detected by SEM-EDS on the surface of Mg-St(+) tablets before and after the 
dissolution for 5 minutes in pH 1.2 medium (a) and pH 6.8 medium (b). Left: surface before 
dissolution; Right: surface after dissolution for 5 minutes. 
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1) Before dissolution 
 
2) After 2 minutes dissolution in pH 1.2 
 
3) After 2 minutes dissolution in pH 6.8 
 
Figure 7  FTIR spectra of Mg-St (-) tablets and Mg-St(+) tablets before and after 2 minutes 
dissolution in pH 1.2 and pH 6.8 media. Left: Mg-St(-) tablets; right: Mg-St(+) tablets. Double arrow 
indicates the peaks of around 2920 and 2850 cm-1. Black thick arrow indicates the peak around 1700 
cm-1 derived from stearic acid. 
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3.5. Dependency of delay of tablet dissolution by Mg-St on dissolution medium pH 
  The delay of tablet dissolution by Mg-St was discussed in the previous part. Its different behaviors 
in different pH media are discussed in the following part. 
  When the initial dissolution rate of Mg-St(+) tablets in pH 1.2 medium was compared to that in 
pH 6.8 medium, as shown in Figure 4, the dissolution in pH 1.2 medium was found to be slower than 
in the pH 6.8 medium. Table 1 indicates that the drug dissolution rates decreased to 47% and 62%, in 
the media of pH 1.2 and 6.8 respectively, by adding Mg-St to the tablets. These findings suggested 
that the contributions of Mg-St to the delay might be larger in pH 1.2 medium than in pH 6.8 
medium. 
  In Figure 7, Mg-St(+) tablets after 2 min of dissolution in pH 1.2 medium displayed one 
characteristic peak at around 1700 cm-1. The region around this peak can be assigned to a carboxylic 
group. Figure 8 shows the IR spectra of stearic acid and Mg-St, obtained by the same procedure as 
that used for the measurement of tablets. Although major parts of both spectra were similar, the peak 
at around 1700 cm-1 was observed only for stearic acid, which is probably derived from carboxylic 
acid C=O. In addition, Mg-St was dispersed on the surface of pH 1.2 and pH 6.8 media overnight, 
and IR spectra of the Mg-St were obtained (Figure 8). The results showed that only Mg-St exposed 
to pH 1.2 medium presented the peak at 1700 cm-1, suggesting the transformation to stearic acid. 
This peak was consistent with the peak observed for Mg-St(+) tablets after dissolution in pH 1.2 
medium. Based on these results, it was suggested that the Mg-St on the tablet surface might 
dissociate to its ions and undergo hydrogenation to form stearic acid in pH 1.2 medium. Such 
changes can occur, as reported in a previous study [28], although their dissolution mechanism is 
different from the one in this study. 
  The solubility of stearic acid is 3 mg/L in water at 20ºC, which is approximately one-tenth of the 
solubility of Mg-St. Therefore, the generation of stearic acid on the tablet surface can cause the 
additional inhibition of tablet dissolution because of its low solubility in acidic medium. Considering 
the pKa of stearic acid (4.95), it is possible that a part of Mg-St near the tablet surface is firstly 
dissolved and immediately hydrogenated to stearic acid by exposure to pH 1.2 medium, which 
contributes to further delay of tablet dissolution. Although Mg-St contains not only magnesium 
stearate but also magnesium palmitate [29], the same behavior is assumed for magnesium palmitate 
since both substances are similar, with only difference in the carbon number. Palmitic acid shows a 
similar IR spectrum to stearic acid, with the characteristic peak at around 1700 cm-1. The solubility 
of palmitic acid in water is as low as that of stearic acid, and this may cause the delay of tablet 
dissolution in the same way. 
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Table 1  Initial dissolution rates of Mg-St(-)and Mg-St(+) tablets 
Dissolution rate in pH 1.2 medium [μg/mL/sec] 
medium Mg-St(-) tablets 
[μg/mL/sec] 
Mg-St(+) tablets 
[μg/mL/sec] 
 
MgSO4 
 
0-2 min 2- 5 min 
Total 
0-2 min 2- 5 min 
Ratio 
(+/-) 
(-) 0.171 0.179 0.176 0.114 0.083 0.47 
(+) 0.167 0.168 0.170 0.108 0.067 0.39 
Ratio(+/-) 
  
0.97  0.81  
 
Dissolution rate in pH 6.8 medium [μg/mL/sec] 
medium Mg-St(-) tablets 
[μg/mL/sec] 
Mg-St(+) tablets 
[μg/mL/sec] 
 
MgSO4 
 
0-2 min 2- 5 min 
Total 
0-2 min 2- 5 min 
Ratio 
(+/-) 
(-) 0.171 0.163 0.169 0.119 0.104 0.62 
(+) 0.155 0.150 0.155 0.101 0.079 0.51 
Ratio(+/-) 
  
0.92  0.76  
*Ratio was calculated with underlined results. 
 
 
 
 
 
Figure 8  IR spectra of stearic acid and Mg-St measured by ATR-FTIR. 1) Stearic acid; 2) Mg-St; 
3) Mg-St exposed to pH 1.2 medium; 4) Mg-St exposed to pH 6.8 medium. Black arrow indicates 
the peak at around 1700 cm-1 characteristic to stearic acid. 
 
  
18 
 
3.6. Delay mechanism of tablet dissolution by Mg-St in acidic and neutral media 
  Based on the investigation results and considerations in this study, the proposed inhibition 
mechanism of tablet dissolution by Mg-St is shown in Figure 9. 
  When the Mg-St(+) tablet is exposed to the dissolution medium, metformin HCl granules dissolve 
faster than Mg-St, because Mg-St is less soluble in water than both metformin HCl and povidone. As 
a result, the area covered by Mg-St increases (Step 1), as confirmed by SEM-EDS and ATR-FTIR 
studies, and effective surface area, reported by Sekiguchi et al [21], decreases. The effective drug 
surface area can be discussed by the results of initial dissolution rates with the stationary disk 
method as follows. The results of the initial dissolution rate measurement correspond to kSCS in Eq. 
(2), and k and CS depend on the combination of drug and dissolution medium. Therefore, the ratio of 
the initial dissolution rate represents the ratio of S (exposed surface area of the drug) of Mg-St(+) 
tablets to S of Mg-St(-) tablets in each medium. In the pH 6.8 medium, the ratio was 0.62, indicating 
38% of the drug surface was covered by Mg-St and thus the effective surface area was decreased by 
38%. 
  The dissolution of Mg-St limits the tablet dissolution (Step 2), as shown in the dissolution studies 
with Mg2+ ions added. The Mg-St(+) tablet dissolution rate decreased in the conditions under which 
the dissociation and dissolution of Mg-St were inhibited. In the case of dissolution in neutral 
medium, the delay mechanism can be explained by Steps 1 and 2 only.  
  In the case of the dissolution of the tablet in acidic medium, one more step contributes to the delay 
of dissolution: the transformation of Mg-St to poorly soluble stearic acid on the tablet surface (Step 
3), as confirmed by ATR-FTIR studies. Calculated in the same way as dissolution in pH 6.8 medium, 
the ratio of the initial dissolution rate of Mg-St(+) tablets to that of Mg-St(-) tablets, 0.47, indicates 
that 53% of the drug surface was covered by Mg-St and stearic acid in pH 1.2 medium. Compared to 
the decreased ratio in pH 6.8 medium, stearic acid may contribute to further decrease the effective 
surface area by 15%. 
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Figure 9  Illustration of delay mechanism of tablet dissolution by Mg-St; Step 1: Exposure of 
Mg-St on tablet surface (in acidic and neutral media); Step 2: Limitation of tablet dissolution by 
Mg-St dissolution (in acidic and neutral media); Step 3: Transformation of Mg-St to poorly-soluble 
stearic acid (only in acidic medium). 
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4. Conclusion 
  Mg-St is a well-known and commonly used lubricant for orally administered solid drug products. 
Therefore, there have been many studies that investigated the quantitative influence of Mg-St on 
rates of drug dissolution from tablets. These studies used tablets containing different amounts of 
Mg-St or tablets manufactured by different process parameters, which led to the investigation of 
potential lot-to-lot variation. The aim of this study was to investigate the mechanism of delay caused 
by Mg-St, and to determine the difference in the delay mechanisms in acidic and neutral media. 
  In this study, some spectroscopic techniques were applied to identify key factors and elucidate the 
mechanism of drug dissolution from metformin tablets containing Mg-St. The molecular-level 
change of Mg-St to stearic acid was detected by FTIR, and micro-level spatial distribution of Mg-St 
on the tablet surface was evaluated by SEM-EDS. As a result, the mechanism by which Mg-St 
inhibits the dissolution of tablets was proposed, and mechanism by which this inhibition is promoted 
in acidic pH environments was elucidated. 
  This research also proposed an evaluation approach using mutually complementary spectroscopic 
techniques that analyze the same question from different aspects would be effective. SEM-EDS and 
FTIR were used to investigate the properties of Mg-St. SEM-EDS detected Mg of Mg-St and FTIR 
detected the stearyl base of Mg-St, and the hypothesis that the amount of exposed Mg-St on the 
tablet surface increases after dissolution was suggested and supported by the findings obtained by 
both methods.  
  The model tablet used in this study was not the rapidly disintegrating type but a surface 
dissolution-type tablet. In the former type of tablet, the phenomenon reported in this study may not 
be observed, because the dissolution of Mg-St would not be a rate-limiting process for tablet 
dissolution. In the latter type of tablet, the same phenomenon as described in this study may occur. 
However, this also depends on the properties of the other components besides Mg-St. If the 
solubility of the drug is lower than that of Mg-St, its dissolution would become a rate-limiting 
process. In this study, the other components of the tablet (metformin HCl and povidone) were 
soluble, and their dissolution was not dependent on the pH of the medium. Therefore, the 
characteristics of Mg-St and the mechanism by which Mg-St causes the delay of tablet dissolution 
could be investigated clearly and separately from the other factors. The phenomenon observed in this 
study may be involved in the dissolution of other tablets in varying degrees, depending on the drug 
product. 
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Study 2: Non-destructive Prediction of Enteric Coating Layer 
Thickness and Drug Dissolution Rate by Near-infrared spectroscopy 
and X-ray computed tomography 
 
1. Background 
  Enteric-coated products are intended to dissolve in the small intestine, not in the stomach, and 
represent one of the controlled-release products which require the proper control of in vivo 
dissolution. One commonly used enteric coating ingredient is pH-dependent polymers, which 
contain carboxylic acid groups. This coating remains undissolved in the low pH of the stomach and 
starts to dissolve slowly in the neutral pH of the small intestine. Thus, the pH-dependent dissolution 
property of the enteric-coated products depends on the solubility and pKa of the drug and coating 
polymer, as well as the properties of the dissolution medium, such as pH and buffer capacity [2]. 
Additionally, it depends on the composition and thickness of the enteric coating layer [30]. 
  Therefore, it is important for pharmaceutical manufacturing process to control the thickness of the 
enteric coating layer that determines the dissolution rate of the drug product to ensure a consistent 
product quality. There are many analytical techniques for investigation of the tablet surface, 
including the film coating layer. Microscopy, such as light microscopy and scanned electron 
microscopy (SEM), can be used to measure the layer thickness directly based on the expanded target 
image; however, cutting the target sample is necessary to expose the cross section of the coating 
layer, which leads to sample destruction. On the contrary, spectroscopy, such as attenuated total 
reflection-Fourier transform infrared (ATR-FTIR), near-infrared (NIR) [31–33], Raman [34,35], and 
terahertz spectroscopy [36], are non-destructive techniques. However, these techniques cannot 
directly measure the layer thickness, but can provide chemical quantitative information as absorption 
of light, from which the information of layer thickness can be derived depending on the optical path 
length. A correlation analysis between the obtained spectrum and the layer thickness allows the 
extraction of information and prediction of the layer thickness. NIR and Raman spectroscopy are 
often used as real-time monitoring techniques during the coating process because of their 
non-destructive nature and quick response [37–39]. Furthermore, combination of spectroscopic and 
imaging techniques can provide more detailed information. Previous studies showed that the spatial 
distribution data of the coating layer thickness can be obtained by NIR chemical imaging (CI) 
[32,40] and terahertz pulsed imaging (TPI) [38,41,42]. 
  These non-destructive techniques enable the data acquisition of both coating layer thickness and 
drug dissolution rate for the same tablet by predictive measurement of the layer thickness followed 
by measurement of the dissolution rate of the same tablet. It is generally known that the coating layer 
thickness of tablets or pellets correlates with the drug dissolution rate [43,44]. Gendre et al. showed 
that the predicted layer thickness correlated with the dissolution rate of the product [45]. This 
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relation is more critical for enteric-coated tablets because of their thick coating layer and slow 
dissolution rate.  
In this study, the correlation between enteric coating layer thickness and drug dissolution rate 
was investigated using several commercial aspirin enteric-coated tablets. Only a few researchers 
studied this relationship for enteric-coated tablets [46]. In addition to NIR, X-ray CT technique was 
adopted for non-destructive measurement of the coating layer thickness distribution. X-ray CT is a 
relatively new but a very strong tool for noninvasive investigation of the internal three-dimensional 
(3D) structures of various objects. It has been applied for monitoring of the dynamic changes inside 
tablets during the dissolution process [47,48] and evaluation of the coating layer thickness of 
particles [49,50]. 
 
 
2. Materials and methods 
2.1 Materials 
2.1.1. Materials 
  Two commercial enteric-coated aspirin 100 mg tablets were used, which were coded as product A 
and B. Only one lot for each product was used. The diameter was approximately 7 mm and the 
average weight was approximately 137 mg for both tablets. Aspirin core tablets of both products 
were prepared by removing the enteric coating layer. 
  The major components were acetylsalicylic acid (aspirin) and crystalline cellulose for aspirin core 
tablets, and methacrylic acid copolymer LD (L30D-55) and talc for enteric coating layer based on 
the information on the product documents. 
  To obtain reference NIR spectra of pure materials, aspirin, methacrylic acid copolymer LD 
(L30D-55), and talc were purchased from Nichi-iko pharmaceuticals (Toyama, Japan), Evonik 
industries (Essen, Germany), and Hayashi Chemicals (Tokyo, Japan), respectively. 
 
2.1.2. Preparation of dissolution medium 
  For the dissolution tests, the 2nd fluid (pH 6.8) provided in the Japanese Pharmacopoeia 17th 
edition (JP17) was used, which was specified as the dissolution medium for release testing of many 
commercial aspirin tablets. 
 
 
2.2 Methods 
2.2.1. NIR measurement  
  A Fourier transform near-infrared spectroscopy (FT-NIR) apparatus (MPA, Bruker, Ettlingen, 
Germany) was used for surface measurement of the tablets. The scanning range was 12500 - 4000 
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cm-1, resolution was 8 cm-1, and scan integration number was 32. Using diffuse reflectance mode 
with an integration sphere, the NIR spectra of the tablet surface were obtained for both sides of each 
tablet as shown in Figure 10. 
 
2.2.2. Measurement of enteric coating layer thickness 
  After NIR measurements, the tablet was cut vertically, as shown in Figure 10, and the cross 
section was observed using a digital microscope (VHX-100, Keyence, Osaka, Japan) attached with a 
zoom lens (VH-Z35, Keyence, Osaka, Japan) under low magnification of ×35. Along the outer 
coating layer of the cross section, the coating layer thickness at the tablet face and side regions was 
measured at more than 30 points at constant intervals.  
  The average coating layer thickness per each side of the tablet face was calculated using the 
thickness values at more than nine points, and represented the dependent variable for preparation of 
the NIR-based calibration model. 
 
2.2.3. Development of a calibration model for coating layer thickness 
  For development of a calibration model using partial least squares (PLS) regression, OPUS 6.5 
software (Bruker, Germany) was applied. For each product, data sets of 41 pairs of the NIR spectra 
and the corresponding enteric coating layer thickness values were prepared for PLS regression. The 
data sets included 40 pairs for each side of the 20 tablets and one pair of the NIR spectrum of aspirin 
core tablet without the coating layer. Test set validation was applied for the calibration model using 
20 data pairs from 10 tablets as “Test” samples, and 21 pairs from the other 11 tablets, including one 
pair of aspirin core tablet, as “Calibration” samples. 
 
2.2.4. Dissolution test 
  A dissolution test apparatus (NTR-6100A, Toyama Sangyo, Osaka, Japan) was used for the 
dissolution tests according to the paddle method described in JP17 using a rotation speed of 75 rpm. 
The test solution of 5 mL was sampled from each vessel at each time point, filtered through a 
0.45-μm membrane filter and the drug concentration was determined by high-performance liquid 
chromatography (HPLC) analysis. 
  An appropriate HPLC apparatus with UV detection unit for the determination purpose was used. 
The determination method by HPLC was validated one, and the HPLC operating conditions were as 
follows: the analytical column was ODS (C18) column, and the mobile phase was a mixture of 
phosphate buffer (pH 6.8) and acetonitrile, UV detection wavelength was 267 nm, and the gradient 
program was applied for the analysis. 
 
2.2.5. X-ray CT measurement for investigation of coating layer thickness 
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  Each tablet was scanned by a microfocus x-ray CT system (inspeXio SMX-100CT, Shimadzu 
Corporation, Kyoto, Japan). The x-ray tube voltage and current were 60 kV and 40 µA, respectively. 
The area of 8.265 × 8.265 × 8.265 mm3 for xyz dimension was scanned at about 16-µm resolution 
(512 × 512 × 512 voxels). The scanning conditions were a view number of 1200 and image average 
of 40 times. The measurement time was approximately 30 min for each tablet. 
  Based on the obtained 3D image of the absorption distribution, the film coating layer thickness 
was evaluated using VGStudioMAX (Volume Graphics, Heidelberg, Germany). The enteric coating 
layer is identified as a high absorption region; thus, the distribution of coating layer thickness was 
analyzed and visualized using the wall thickness analysis option. 
 
 
 
Figure 10  Illustration of the cross-section of aspirin enteric coated tablets. The area measured by 
NIR is presented by the arrow. The boundary is also presented which was set at 0.5 mm inside from 
the tablet edge to separate between the face and side regions for analysis of the coating layer 
thickness distribution. 
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3. Results and Discussion 
3.1. Preparation of calibration models for evaluation of coating layer thickness of each product 
by NIR 
  Calibration models of enteric coating layer thickness were separately developed for product A and 
B because the coating layer composition of products A and B was supposed to be different looking 
into each product document. Based on the direct observation using the digital microscope, the layer 
thickness varied between 64 and 127 μm for product A, and between 71 and 133 μm for product B.  
  The major components of the enteric coating layer were methacrylic acid copolymer LD and talc. 
To determine the adequate wavenumber range in the NIR spectra to calibrate the coating layer 
thickness, the NIR spectra of the major components and core tablets were compared as shown in 
Figure 11. Because of the high aspirin content ratio, which was more than 73 % (100 mg aspirin in 
about 137 mg of tablet), the major component of the core tablet was aspirin; thus, the NIR spectra of 
the core tablets of products A and B corresponded to aspirin. A spectral difference between the 
coated tablet and core tablet was clearly observed at the regions at approximately 8500, 7200, 6000, 
and 4300 cm-1. These differences should indicate an increase in the contribution of the coating 
materials, such as methacrylic acid copolymer LD and talc, as well as a decrease in the contribution 
of aspirin. 
  The characteristic absorption bands at 8480, 5960, 5800, 4430, and 4360 cm-1 were due to 
methacrylic acid copolymer, whereas the bands at 8840 and 6040 cm-1 were due to aspirin. The 
characteristic sharp absorption bands of talc were observed at 7190 and 4330 cm-1. Additionally, the 
broad absorption bands of water were observed at the regions around 7000 and 5200 cm-1. Therefore, 
spectral differences at approximately 8500, 7200, and 8800 cm-1 were attributed to the polymer, talc, 
and aspirin, respectively. Moreover, differences in the bands at approximately 6000 cm-1 were 
attributed to the polymer and aspirin. These regions should be included in the wavenumber range of 
the calibration model. 
  Thus, these wavenumber ranges were evaluated for the calibration model, (i) 12500-4000 cm-1 of 
the full range, (ii) 10000-4000 cm-1 without noisy range, and (iii) 10000-5500 cm-1 without 
water-derived absorption range. Additionally, as a preprocessing of NIR spectra, a standard normal 
variate (SNV), first derivative (FD, smoothing point: 17), or second derivative (SD, smoothing 
point: 17) was examined prior to PLS calibration. For product A, the root-mean-square error of 
prediction (RMSEP) of the validation results showed the smallest value (8.1 µm) and the coefficient 
correlation value was the highest when the PLS calibration was performed at the range of (i) 
12500-4000 cm-1 with second derivative as a preprocessing and the number of explanatory variables 
(rank) was 2. The calibration curve and its regression spectrum are shown in Figure 12A. The curve 
indicated a good correlation (R2 = 0.8683), and the regression spectrum appropriately detected the 
changes in the absorption bands attributed to aspirin, methacrylic acid copolymer, and talc. This 
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model was determined for the calibration of enteric coating layer thickness of product A. 
  Similarly, the calibration model for product B was optimized, as shown in Figure 12B. The 
parameters were determined based on the optimization study as follows: the range was 10000-4000 
cm-1 with first derivative as the preprocessing and the number of explanatory variables (rank) was 3 
(RMSEP = 5.21 m). Good correlation was confirmed with R2 = 0.8772. The regression spectrum 
suggested that this calibration model for product B was based on the chemical information of talc 
and aspirin. The resulting RMSEP value was sufficiently low owing to the coating roughness. 
  The regression spectra of the calibration models of products A and B were different. The model 
for product A was mainly contributed by the aspirin quantity decrease according to the increase in 
the coating layer thickness, whereas the contribution of aspirin quantity was not high for the model 
of product B, which was mainly contributed by the quantity of talc in enteric coating layer. The 
differences in the composition and density of the enteric coating layer between these products 
resulted in these different calibration models. 
 
 
 
Figure 11  NIR spectra for products A and B and their components 
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Figure 12  Calibration curve and regression spectrum of NIR calibration model for enteric coating 
layer thickness. A: product A (upper, 12500-4000 cm-1, second derivative, rank 2); B: product B 
(lower, 10000-4000 cm-1, first derivative, rank 3) 
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3.2. Prediction of the coating layer thickness and drug dissolution rates 
  To investigate the relation between the enteric coating layer thickness and drug dissolution rate, 
NIR spectra were collected for another twenty-four samples of product A and eighteen samples of 
product B, which were of the same lot as that of the tablets used for preparing the calibration models. 
The calibration models were used for predicting the coating layer thickness based on the collected 
spectra. The average layer thickness was calculated at both faces for each tablet. Following the NIR 
measurements, these tablets were applied to the dissolution testing, and their variable dissolution 
profiles are shown in Figure 13. 
  The % dissolved aspirin at 45 and 60 min was plotted as a function of the predicted coating layer 
thickness, as shown in Figure 14. The results of regression analysis are summarized in Table 2. It is 
known that the dissolution rate decreases with the increase in the coating layer thickness. This 
inverse relation was expectedly observed for product A at both time points as shown in Figure 14A: 
the correlation coefficient between dissolution% at 45 and 60 minutes and predicted thickness was 
-0.6575 and -0.6334, respectively, and the slope of both regression lines were statistically significant 
(p<0.01). Generally, the value of correlation coefficient less than -0.6 or larger than 0.6 indicates that 
those two values have the negative or positive correlation, respectively. Compared to the results for 
product B in Figure 14B where the correlation coefficient was 0.4001 and 0.2786 and the slope of 
regression lines was not statistically significant, it is concluded that the correlation was observed for 
product A. This negative correlation is consistent with the general knowledge about dissolution% 
and coating thickness. 
 
Figure 13  Individual dissolution profiles of products A and B 
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Figure 14  Relationship between % dissolved aspirin and predicted coating layer thickness for 
products A and B. The regression line is presented in each figure. 
 
 
Table 2  Correlation between % dissolved and predicted coating layer thickness 
 % dissolved at 45 min % dissolved at 60 min vs. 
Sample Slope Intercept Correlation 
Coefficient 
Slope Intercept Correlation 
Coefficient 
A -1.412 
 
177.1 -0.6575 
(p=0.0005) 
-0.4302 
 
122.3 -0.6334 
(p=0.0009) 
B 2.438 
 
-140.3 0.4001 
(p=0.0999) 
1.531 
 
-48.15 0.2786 
(p=0.2629) 
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3.3. Micro X-ray CT analysis of coating layer thickness distribution 
  Because the predicted coating layer thickness did not correlate with the drug dissolution rate, 
other factors might contribute to the drug dissolution of product B. Microscopic determination of the 
thickness distribution was necessary because NIR analysis could only provide the average 
macroscopic thickness of the target sample [32]. Although there are some techniques for microscopic 
measurements, including NIR-CI [32,40], Raman mapping [38], and TPI [41,42], X-ray CT was 
selected in this study because of its non-destructive nature and high spatial resolution. Additionally, 
X-ray CT directly provides the coating layer thickness; thus, it is an appropriate technique to 
determine the coating layer thickness and its distribution [50,51]. 
  Three tablets for each of products A and B were scanned by X-ray CT system, and the 3D data of 
the X-ray absorption distribution was obtained. The extracted longitudinal section figures are shown 
in Figure 15. The absorption distribution is represented by a gray scale, where the color gradient 
from black to white corresponds to the gradient from low to high absorption. The enteric coating 
layer was clearly distinguished from the inner aspirin core tablet owing to the difference in the 
densities [52,53] and X-ray absorption properties of the materials. Thus, the outer region of high 
absorption area was determined to the enteric coating layer part. The distribution of the coating layer 
thickness was calculated for the whole tablet and mapped by color in Figure 16, where the color 
gradient from blue to red corresponds to the gradient from thin to thick layer. 
  As shown in Figure 16, the 3D images expressed green wholly and showed that the thickness was 
entirely constant within the tablet, including the faces, sides, and edges for any tablet of product A, 
which indicated intra-tablet homogeneity. On the contrary, two of three tablets of product B, shown 
in Figure 16 B-1 and B-3, expressed blue on the side regions in addition to green and showed an 
intra-tablet heterogeneous distribution of the coating layer thickness. The thickness at the sides and 
edges was less than that at the face regions. In order to evaluate the differences between the face and 
side regions quantitatively, the coating layer of each tablet was divided into two parts that 
represented the face and side regions based on the boundary shown in Figure 10. Then, the 
histograms of the layer thickness were constructed for each region of the tablets. All histograms of 
the six tablets are shown in Figure 17. Based on the histogram, the average thickness of each region 
of the tablets was summarized in Table 3. The average thickness was equal at the face and side 
regions for product A, whereas product B showed different average thickness at the face and side 
regions. In addition, the histogram of product A was symmetric, whereas that of product B was 
distorted and not symmetric, which indicated the heterogeneity of the coating layer thickness. It was 
suggested that the localized thin coating layer observed in tablets B-1 and B-3 might result in fast 
drug dissolution despite the equal thickness at the face regions to the other tablets. 
  These six tablets scanned by X-ray CT system were applied to the dissolution testing. Both 
products A and B showed similar dissolution patterns: (1) the horizontal crack first appeared on the 
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side region of the tablet, as shown in Figure 18, (2) the crack expanded to the whole side of the tablet, 
and (3) finally, the tablet disintegrated into two parts. The dissolved drug amounts were determined 
by HPLC, and the dissolution profile of each tablet is shown in Figure 18.  
  For product A, the crack appeared on the side region in the order of: A-3 (approximately 15 min), 
A-2 (approximately 17 min), and A-1 (approximately 19 min). Subsequently, the tablets 
disintegrated into two parts at approximately 32, 33, and 43 min for tablets A-2, A-3, and A-1, 
respectively. For product B, the crack appeared at 20, 22, and 25 min, and the tablet disintegrated at 
35, 42, and 47 min for tablets B-3, B-2, and B-1, respectively. We observed that, by comparison of 
the observation with the drug dissolution profiles, the dissolution started at the time of cracking, and 
accelerated after the tablet disintegration. Crack formation is the critical step that determines the 
dissolution process; in addition, we suggest that the coating layer thickness at the side regions is the 
critical factor that affects crack formation. By comparison with the coating layer thickness at the side 
regions in Table 3, the perfect correlation between the average thin layer thickness at the side regions 
and the early crack formation was not observed. This would be due to the contribution of the micro 
spot of thinner layer thickness to the crack, however, it would be clear that thin layer thickness 
distribution at the side regions could contribute to the early crack formation. 
 
 
Figure 15  Longitudinal section images obtained using X-ray CT system for products A and B. The 
color gradient from black to white corresponds to the gradient from low to high absorption. The 
white part corresponds to the enteric coating layer part. 
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Figure 16  Color images of distribution of coating layer thickness of each six tablets. The color 
gradient from blue to red corresponds to the gradient from thin to thick layer thickness (0 - 150 μm).  
 
33 
 
 
Figure 17  Separate histograms of coating layer thickness distribution for the face and side regions 
of the tablets. The horizontal axis represents the layer thickness from 0 to 150 μm. 
 
 
Table 3  Coating layer thickness at the face and side regions of each tablet 
 Thickness (m) 
Sample 1 2 3 
Ave. ± SD Ave. ± SD Ave. ± SD 
A 
Face 90.3 ± 9.04 71.0 ± 6.50 91.8 ± 10.5 
Side 87.3 ± 10.9 71.1 ± 9.28 89.8 ± 11.2 
B 
Face 85.5 ± 12.1 89.4 ± 13.8 75.9 ± 12.1 
Side 55.7 ± 11.7 99.3 ± 6.87 40.6 ± 7.71 
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Figure 18  Individual dissolution profiles of the six tablets measured by X-ray CT system along 
with pictures of the crack on the tablet side 
 
 
 
  
35 
 
3.4. Prediction of dissolution rate by evaluation of coating layer thickness 
  The face regions of the tablet are usually measured in the off-line NIR analysis. For intra-tablet 
homogeneous products, the coating layer thickness at the face regions can represent the whole tablet. 
However, NIR analysis of the face regions is not applicable for intra-tablet heterogeneous products. 
Even if there is a difference in the coating layer thickness between the face and side regions, the 
consistent relationship between the thickness of the face and side regions may enable the prediction 
of the whole thickness and the dissolution rate. However, for product B, the heterogeneous 
relationship did not allow the prediction of the coating layer thickness and dissolution rate. 
  The development of manufacturing processes to ensure uniform film coating is complex and 
difficult [54]. Many factors can affect the roughness and homogeneity of the coating layer thickness, 
such as the composition of film coating suspension, types of enteric coating components [30], and 
coating process parameters [42,55]. Therefore, the difference in the roughness of the tablet surface, 
composition of enteric film layer, and coating process parameters might result in the intra-tablet 
heterogeneity and inter-tablet inconsistency for product B. 
  For evaluation and control of the dissolution property of tablets, it is important to understand the 
critical attributes that affect the drug dissolution rate. In this study, based on the X-ray CT 
measurements and observation of the tablet dissolution process, it was revealed that the critical 
attribute that affected the drug dissolution rate was the enteric coating layer thickness at the side 
regions of the tablets, which directly influenced the rate of tablet split and the subsequent drug 
dissolution. Although X-ray CT particularly provided information about the coating layer thickness 
distribution of the whole tablet including the side regions, it required much longer time than NIR. 
Actually, NIR is generally applied during the manufacturing process as a PAT tool owing to its 
flexible application and fast response. Moreover, NIR-based PAT was used in the coating process of 
tablets to predict the amount of the coating material required [31,37]. However, our results showed 
that not only the total coating amount but also the coating thickness of the side regions was critical 
attribute to control the quality of products. Thus, heterogeneous tablet coating leads to a 
disagreement between the coating amount and the coating thickness of the side regions, resulting in a 
disagreement between the coating amount and the drug dissolution rate. Therefore, to control drug 
dissolution rate, the coating amount and coating thickness of the face regions should be proportional 
to that of the side regions and to the dissolution rate. We suggest that homogeneous tablet coating is 
important to ensure the quality of the final products.   
 
 
4. Conclusion 
  In this study, the molecular-level data derived from carboxylic group of aspirin and methacrylic 
acid copolymer and hydroxylic group of talc were obtained, and the enteric coating layer thickness 
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was determined by off-line NIR spectroscopic analysis. Additionally, the correlation between the 
thickness and drug dissolution rate was investigated to evaluate the predictability of the dissolution 
profile from the thickness. If the dissolution profile can be predicted based on the thickness, NIR 
monitoring of the coating process is useful to control the drug dissolution. However, the 
NIR-predicted thickness correlated with the dissolution rate only for tablets with homogeneous 
coating, and cannot be applied for the other tablets. The coating layer thickness must be 
homogeneous within each tablet, or the trend in distribution of the coating layer thickness must be 
consistent between the tablets to enable the prediction of drug dissolution rate. Many studies have 
shown that X-ray CT is a very useful tool to determine the distribution of the coating layer thickness 
of the whole tablet or particle [49,50]. In this study, the micro-level spatial data of X-ray absorption 
was obtained by X-ray CT, and the distribution of layer thickness for the whole tablet was calculated 
based on the data, which revealed the homogeneity and heterogeneity of the layer thickness 
distribution of the whole tablet, including the side regions, and enabled separate analysis of the 
divided parts. The application of micro- and macro-spectroscopic approaches to the enteric coating 
layer enabled identification of the factors determining the dissolution and revealed the correlation 
between enteric film-coating layer properties and dissolution of the tablet. 
  It is important to investigate and fully understand the processes that affect the final properties, 
such as drug dissolution, prior to the development of any prediction model. The prediction model is 
often based only on macroscopic measurements. However, microscopic measurements are 
recommended as a complementary technique. The combination approach using the macro- and 
micro-analysis is useful to understand the pharmaceutical properties, such as dissolution rate. We 
suggest that investigation of the pharmaceutical properties by several techniques enables the 
establishment of proper prediction models. 
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Overall Conclusion 
 
  In these two studies, some spectroscopic techniques were applied to identify key factors and 
elucidate the mechanism of drug dissolution from orally administered solid dosage forms by 
monitoring of the chemical change of the target material at molecular level and micro-level spatial 
analysis of targets. In the first study, the molecular-level change of Mg-St to stearic acid was 
detected by FTIR, and micro-level spatial distribution of Mg-St on the tablet surface was evaluated 
by SEM-EDS. As a result, the mechanism by which Mg-St inhibits the dissolution of tablets was 
proposed, and mechanism by which this inhibition is promoted in acidic pH environments was 
elucidated by spectroscopic approaches. In the second study, the molecular-level data derived from 
carboxylic group of aspirin and methacrylic acid copolymer and hydroxylic group of talc were 
obtained by NIRS, and utilized for calculation and prediction of the thickness of enteric-coating 
layer containing those materials. In addition, the micro-level spatial data of X-ray absorption was 
obtained by X-ray CT, and the distribution of layer thickness for the whole tablet was calculated 
based on the data. The application of micro- and macro-spectroscopic approaches to the enteric 
coating layer enabled identification of the factors determining the dissolution and revealed the 
correlation between enteric film-coating layer properties and dissolution of the tablet. As such, 
spectroscopic approaches for examination of the dissolution of orally administered drug products 
were established successfully through these studies. 
  The studies provided one important suggestion. Spectroscopic techniques cannot provide direct 
information; the spectrum data represent the light absorption or scattering attributable to factors such 
as the functional groups and arrangement of molecules, and does not present the target results 
directly. Therefore, it is important to apply more than one technique to demonstrate a hypothesis. In 
the first study, SEM-EDS and FTIR were used to investigate the properties of Mg-St. SEM-EDS 
detected Mg of Mg-St and FTIR detected the stearyl base of Mg-St, and the hypothesis that the 
amount of exposed Mg-St on the tablet surface increases after dissolution was suggested and 
supported by the findings obtained by both methods. This research proposed an evaluation approach 
using mutually complementary spectroscopic techniques that analyze the same question from 
different aspects would be effective. 
  The results of the second study provide another approach using mutually complementary 
techniques. A macroscopic technique like NIRS and a microscopic technique like X-ray CT each 
have its unique advantages and disadvantages. Generally, macroscopic techniques provide results 
quickly, but the resolution of the results may be not high. In contrast, microscopic techniques can 
provide detailed data, but they require more time to measure and analyze the results. The balance 
between the operation time and the resolution of the data obtained should be considered depending 
on the purpose. The research results demonstrated the importance of a microscopic evaluation before 
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a macroscopic evaluation, e.g., by investigation of layer thickness distribution by X-ray CT before 
monitoring of total coating amount by NIRS in this case. Here, it was important to apply both 
macro- and microscopic techniques, which are also considered mutually complementary, to the same 
target. 
  Spectroscopic techniques offer such challenges; however, they are useful and appropriate tools for 
investigation of the dissolution properties and mechanisms of drug products due to their ability to 
perform nondestructive prediction of physicochemical properties or real-time monitoring of dynamic 
physicochemical properties. The important point is to apply spectroscopic techniques with a full 
understanding of their characteristics and limitations. 
  While these two studies yielded analytical knowledge and established the techniques, they also 
provided some suggestions for product quality and pharmaceutical product development. The results 
of the first study indicated the potentially different behavior of Mg-St in acidic and neutral pH 
environments. This might suggest a change from Mg-St to another lubricant, e.g., a lubricant 
showing constant solubility in the physiological pH range or a more soluble lubricants [5]. When 
testing a new lubricant, the approach employed to evaluate the behavior of Mg-St in this study may 
be used to evaluate the new lubricant. The results of the second study showed the importance of 
thickness homogeneity of the film coating layer. Even when the film coating process is controlled 
and monitored by PAT tools like NIR, the homogeneity of the film layer thickness should be ensured 
beforehand. It is generally known that the PK profiles of aspirin enteric-coated tablets show much 
variation, thus the enteric-coating layer thickness should be kept consistent between tablets with 
intra-tablet homogeneity to avoid the dissolution variation between tablets that potentially contribute 
to the PK variation. Similarly, when the evaluation procedure is established using noninvasive 
spectroscopic techniques and the key factors determining dissolution are identified, provision of 
feedback to pharmaceutical product quality becomes possible. 
  In conclusion, some spectroscopic approaches were established for identification of key factors 
and elucidation of the mechanism of drug dissolution from orally administered solid dosage forms 
such as IR tablets and enteric-coated tablets. These approaches could be applied for other types of 
drug products, and could contribute to pharmaceutical product development, which is becoming 
increasingly complex. In addition, these results may contribute to advancement of the field of 
formulation development. 
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